Provided by Tiger Fintech (Singapore) Pte. Ltd.

Checkpoint Therapeutics, Inc.

4.01
-0.0300-0.74%
Post-market: 3.99-0.0200-0.50%18:36 EDT
Volume:1.94M
Turnover:7.77M
Market Cap:335.89M
PE:-2.82
High:4.03
Open:4.02
Low:3.99
Close:4.04
Loading ...
Jun 11, 2021

Major Issues Report

8-K - Current report
May 07, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
May 07, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2021

Major Issues Report

8-K - Current report
Mar 12, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 07, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 17, 2020

Major Issues Report

8-K - Current report
Dec 15, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 27, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Nov 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2020

Major Issues Report

8-K - Current report
Oct 07, 2020

Major Issues Report

8-K - Current report
Sep 25, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 21, 2020

Major Issues Report

8-K - Current report
Sep 18, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Sep 18, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 17, 2020

Major Issues Report

8-K - Current report